The Evolution of the Use of β-Blockers to Treat Heart Failure
| Autor: | John D. Rutherford, Finn Waagstein |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Gerontology
medicine.medical_specialty business.industry media_common.quotation_subject education Cardiomyopathy 030204 cardiovascular system & hematology medicine.disease University hospital humanities 03 medical and health sciences 0302 clinical medicine Physiology (medical) Heart failure Family medicine medicine University medical Conversation 030212 general & internal medicine Cardiology and Cardiovascular Medicine business Associate professor health care economics and organizations media_common |
| Zdroj: | Circulation. 136:889-893 |
| ISSN: | 1524-4539 0009-7322 |
| DOI: | 10.1161/circulationaha.117.029934 |
| Popis: | Finn Waagstein was born in Copenhagen in 1938. He graduated from Aarhus University Medical School in 1964. He received his cardiology training in the Sahlgrenska University Hospital at the University of Gothenburg, Sweden. He was appointed Associate Professor in 1980, and he assisted in establishing and directing the first Swedish heart transplant program. From 1990 he directed the heart failure and cardiomyopathy research programs. He is currently Professor of Cardiology and senior physician at Wallenberg Laboratory. In 2002, he was awarded the King Faisal International Prize for Medicine. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|